A SINGLE BLIND, RANDOMIZED, CROSS-OVER STUDY IN HEALTHY ADULT PARTICIPANTS TO INVESTIGATE THE PALATABILITY OF ORAL FORMULATIONS OF PF-06651600 FOR PEDIATRIC USE
Latest Information Update: 10 Jun 2019
At a glance
- Drugs Ritlecitinib (Primary)
- Indications Alopecia areata; Crohn's disease; Rheumatoid arthritis; Ulcerative colitis; Vitiligo
- Focus Therapeutic Use
- Acronyms Taste Study
- Sponsors Pfizer
Most Recent Events
- 04 Jun 2019 Status changed from recruiting to completed.
- 14 May 2019 Status changed from not yet recruiting to recruiting.
- 18 Apr 2019 New trial record